These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10896543)

  • 1. Effect of ramipril on cardiovascular events in high-risk patients.
    Weinsaft JW
    N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the relevance of the HOPE study in general practice?
    Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
    Int J Clin Pract; 2001 Sep; 55(7):449-57. PubMed ID: 11594254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HOPE study: comparison with other trials of secondary prevention.
    Otterstad JE; Sleight P
    Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ramipril on cardiovascular events in high-risk patients.
    O'Rourke MF; Nichols WW
    N Engl J Med; 2000 Jul; 343(1):64-5; author reply 66. PubMed ID: 10896544
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk reduction for stroke and coronary events.
    Peverill RE
    Lancet; 2002 Apr; 359(9313):1249; author reply 1250-1. PubMed ID: 11955568
    [No Abstract]   [Full Text] [Related]  

  • 6. ACE inhibitors to prevent cardiovascular events in high-risk patients.
    VandeKieft GK
    J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
    [No Abstract]   [Full Text] [Related]  

  • 7. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors and high-risk patients.
    Myers KA
    CMAJ; 2000 Aug; 163(3):327. PubMed ID: 10951738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sex differences and cardiovascular drugs].
    Løchen ML; Kvan E
    Tidsskr Nor Laegeforen; 2010 Feb; 130(4):382-4. PubMed ID: 20220863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition in cardiovascular disease.
    Francis GS
    N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
    Hathial M
    J Indian Med Assoc; 2008 Jul; 106(7):468-70, 480. PubMed ID: 18975506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramipril.
    Smith WH; Ball SG
    Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk in patients with type 2 diabetes.
    Shanks M; Holmes DT; Cermakova L; Frohlich J
    CMAJ; 2005 Apr; 172(9):1160-1. PubMed ID: 15851694
    [No Abstract]   [Full Text] [Related]  

  • 15. [The reduction of cardiovascular risk with ramipril].
    Vanuzzo D
    Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
    [No Abstract]   [Full Text] [Related]  

  • 16. [The HOPE Study. What does it contribute to general practice?].
    Mann J; Sleight P
    MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb; 12(2):127-37. PubMed ID: 8605634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future perspectives and implications.
    Sleight P
    Int J Clin Pract Suppl; 2001 Jan; (117):22-3. PubMed ID: 11715355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.